8 years of historical data (2018–2025) · Healthcare · Medical - Healthcare Information Services
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
American Well Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $119M | $79M | $109M | $424M | $776M | $1.5B | $2.5B | — | — |
| Enterprise Value | $-58693787 | $-99011011 | $-111365000 | $63M | $252M | $805M | $1.6B | — | — |
| P/E Ratio → | -1.20 | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.48 | 0.32 | 0.43 | 1.64 | 2.80 | 6.07 | 10.23 | — | — |
| P/B Ratio | 0.46 | 0.32 | 0.34 | 0.88 | 0.72 | 1.22 | 2.01 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | -0.40 | -0.44 | 0.24 | 0.91 | 3.18 | 6.42 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
American Well Corporation earns an operating margin of -42.2%. Operating margins have expanded from -267.2% to -42.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -33.9% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.3% | 53.3% | 38.9% | 36.6% | 42.1% | 41.3% | 36.1% | 46.3% | 48.6% |
| Operating Margin | -42.2% | -42.2% | -85.5% | -267.2% | -99.5% | -70.9% | -92.7% | -63.6% | -48.4% |
| Net Profit Margin | -38.4% | -38.4% | -81.8% | -260.6% | -97.6% | -69.8% | -91.5% | -58.6% | -46.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROE | -33.9% | -33.9% | -52.3% | -86.3% | -23.1% | -14.1% | -27.7% | -23.4% | -14.2% |
| ROA | -25.2% | -25.2% | -40.6% | -74.7% | -20.3% | -12.5% | -23.9% | -17.6% | -10.8% |
| ROIC | -95.1% | -95.1% | -151.0% | -152.7% | -37.9% | -31.9% | -60.6% | -24.7% | — |
| ROCE | -36.6% | -36.6% | -53.0% | -86.5% | -22.9% | -14.0% | -27.6% | -23.8% | -13.7% |
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $182M exceeds total debt of $5M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.02 | 0.02 | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 | 0.04 | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.72 | -0.70 | -0.75 | -0.48 | -0.58 | -0.75 | -0.33 | -0.13 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($182M) exceeds total debt ($5M)
Short-term solvency ratios and asset-utilisation metrics
American Well Corporation's current ratio of 3.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 4.79x to 3.37x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.37 | 3.37 | 2.85 | 4.79 | 5.49 | 5.84 | 9.20 | 2.10 | 3.42 |
| Quick Ratio | 3.35 | 3.35 | 2.82 | 4.72 | 5.42 | 5.79 | 9.13 | 2.07 | 3.39 |
| Cash Ratio | 2.49 | 2.49 | 2.05 | 3.97 | 4.72 | 5.27 | 8.61 | 1.67 | 2.92 |
| Asset Turnover | — | 0.77 | 0.58 | 0.44 | 0.23 | 0.17 | 0.18 | 0.30 | 0.23 |
| Inventory Turnover | 98.12 | 98.12 | 54.38 | 24.70 | 18.36 | 19.72 | 17.18 | 25.77 | 23.33 |
| Days Sales Outstanding | — | 72.75 | 103.15 | 76.29 | 76.86 | 74.18 | 67.41 | 80.25 | 98.58 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
American Well Corporation returns 0.0% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 1.0% | 1.5% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 1.0% | 1.5% | — | — |
| Shares Outstanding | — | $16M | $15M | $14M | $14M | $13M | $5M | $2M | $2M |
Compare AMWL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $119M | -1.2 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — | |
| $1B | -6.0 | 14.8 | 4.3 | 69.5% | -10.4% | -13.9% | -11.5% | 10.4 | |
| $5B | 23.1 | 20.8 | 19.4 | 90.2% | 39.9% | 22.5% | 20.0% | 0.1 | |
| $7B | 52.7 | 44.5 | 93.8 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 | |
| $121M | 24.0 | 6.4 | 6.5 | 67.3% | 10.7% | 4.2% | 7.1% | 0.3 | |
| $869M | 129.8 | 138.1 | — | 43.0% | 1.4% | 6.6% | 3.9% | — | |
| $1B | -15.8 | — | — | 103.6% | -4.4% | -26.3% | -34.0% | — | |
| $712M | 28.6 | 2.9 | 9.3 | 92.8% | 11.0% | 12.3% | 10.6% | 0.3 | |
| $3B | 133.3 | 57.6 | 18.6 | 9.9% | 1.6% | 3.1% | 9.9% | 0.2 | |
| $27B | 30.8 | 28.2 | 19.2 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 | |
| $111M | -0.6 | — | — | 48.7% | -51.7% | -58.3% | -32.9% | — | |
| Healthcare Median | — | 22.2 | 14.1 | 18.6 | 64.1% | -5.3% | -34.0% | -11.2% | 3.1 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 8 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Teladoc Health, Inc..
Start ComparisonQuick answers to the most common questions about buying AMWL stock.
American Well Corporation's current P/E ratio is -1.2x. This places it at the 50th percentile of its historical range.
American Well Corporation's return on equity (ROE) is -33.9%. The historical average is -34.4%.
Based on historical data, American Well Corporation is trading at a P/E of -1.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
American Well Corporation has 53.3% gross margin and -42.2% operating margin.